Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 4Other hematologic neoplasm 2Lymphoid 2Sarcoma 1

Conditions

Lymphoma, Non-Hodgkin 9Lymphoma 9Hodgkin Disease 9Precursor Cell Lymphoblastic Leukemia-Lymphoma 7Leukemia 7Leukemia, Myeloid, Acute 6Multiple Myeloma 5Lymphoma, Large B-Cell, Diffuse 5Myelodysplastic Syndromes 4Leukemia, Lymphocytic, Chronic, B-Cell 4Lymphoma, Mantle-Cell 3Lymphoma, Large-Cell, Immunoblastic 3Lymphoma, Follicular 3Lymphoma, B-Cell, Marginal Zone 3Burkitt Lymphoma 3Blast Crisis 3Stomatitis 2Recurrence 2Neoplasms, Plasma Cell 2Lymphoma, T-Cell 2Leukemia, Myeloid, Chronic-Phase 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Sezary Syndrome 1Radiation Injuries 1Primary Myelofibrosis 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms 1Myeloproliferative Disorders 1Mycosis Fungoides 1

Interventions

Cyclophosphamide 59fludarabine phosphate 52Peripheral Blood Stem Cell Transplantation 40Busulfan 39Tacrolimus 35Antilymphocyte Serum 34Mycophenolic Acid 33Radiotherapy 30Filgrastim 28Cyclosporine 25Melphalan 24Methotrexate 22Whole-Body Irradiation 21fludarabine 20Methylprednisolone 17Etoposide 16Cord Blood Stem Cell Transplantation 15sargramostim 9Rituximab 9Granulocyte Colony-Stimulating Factor 9Cytarabine 9Bortezomib 9Alemtuzumab 9Sirolimus 8Epoetin Alfa 7Psychiatric Rehabilitation 6Prednisone 6Flow Cytometry 6Carmustine 6Trimethoprim, Sulfamethoxazole Drug Combination 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Neoplasms, Plasma Cell × Fibroblast Growth Factor 7 × Lymphoid × Clear all
NCT00410982 2016-06-03

Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid Malignancies

M.D. Anderson Cancer Center

Phase 1 Completed
145 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell

NCT00004132 2013-06-26

Growth Factor to Prevent Oral Mucositis in Patients With Hematologic Cancer

National Cancer Institute (NCI)

Phase 2 Completed
LymphoidOther hematologic neoplasmPlasma cellSarcoma

Blast Crisis, Burkitt Lymphoma, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Radiation Injuries, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Acute, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Dendritic Cell Sarcoma, Interdigitating, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡